Literature DB >> 10416112

[Cost of early management of chronic inflammatory intestinal disease].

N Rolland1, B Grandbastien, V Merle, C Gower-Rousseau, T Yzet, R Marti, E Lerebours, J L Dupas, P Czernichow, J L Salomez, T Lebrun, A Cortot.   

Abstract

OBJECTIVES: The aim of this study was to assess the cost of the first management of inflammatory bowel disease (IBD) from the onset of first symptoms until 6 weeks after the diagnosis. This cost was calculated in French francs (FF) for all IBD and namely for Crohn's disease (CD), ulcerative colitis (UC), and ulcerative proctitis (UP).
MATERIAL AND METHODS: Data concerning 258 patients were collected by the mean of a standardized questionnaire from 3 different sources: the patient, his general practitioner, and his gastroenterologist.
RESULTS: Two hundred and fifty eight patients were included: 144 CD (55.8%), 76 UC (29.5%), 30 UP (11.6%), and 8 chronic unclassifiable colitis (CUC) (3.1%). The mean direct costs of the diagnosis (m +/- SD) were 23,116 +/- 40,820 FF for CD, 10,628 +/- 17,316 FF for UC and 3,451 +/- 2,743 FF for UP. Although unplanned hospitalizations occurred in only 38% of the patients (98/258), they represented the 3/4 of the mean costs: 78.2% for CD and 64% for UC. Indirect costs generated by days off work were 4,719 +/- 6,610 FF for CD, 2,996 +/- 6,897 FF for UC and 1,230 +/- 3,622 FF for UP.
CONCLUSION: The first management of a patient with CD was twice more expensive than the one with UC and 6.5 times than the one with UP.

Entities:  

Mesh:

Year:  1999        PMID: 10416112

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  1 in total

1.  Inflammatory bowel diseases and the general practitioner's role in a region of Central Italy.

Authors:  Paolo Sossai; Fabio Filippetti; Ali Ahmad Muselmani; Giambattista Catalini
Journal:  Clin Exp Gastroenterol       Date:  2010-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.